TherapeuticsMD (TXMD) Share-based Compensation Growth (1y) (2011 - 2026)
TherapeuticsMD (TXMD) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 300.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300.00% |
| Mar 31, 2026 | -91.30% |
| Dec 31, 2025 | 112.50% |
| Jun 30, 2025 | -98.96% |
| Mar 31, 2025 | -79.28% |
| Dec 31, 2024 | -79.31% |
| Sep 30, 2024 | -85.84% |
| Jun 30, 2024 | -78.03% |
| Mar 31, 2024 | -77.02% |
| Dec 31, 2023 | -89.45% |
| Sep 30, 2023 | -96.18% |
| Jun 30, 2023 | -96.42% |
| Mar 31, 2023 | -76.56% |
| Dec 31, 2022 | -79.25% |
| Sep 30, 2022 | -16.44% |
| Jun 30, 2022 | 5,250.88% |
| Mar 31, 2022 | 4,022.00% |
| Dec 31, 2021 | 140.91% |
| Sep 30, 2021 | 135.48% |
| Jun 30, 2021 | -92.40% |